» Articles » PMID: 29915613

Leadless Pacemakers: a Contemporary Review

Overview
Specialty Geriatrics
Date 2018 Jun 20
PMID 29915613
Citations 27
Authors
Affiliations
Soon will be listed here.
Citing Articles

Impact of body mass index on in-hospital outcomes in patients receiving leadless pacemakers: A five-category analysis.

Sagoo R, Sagoo N, Haider A, Sathyamoorthy M Heart Rhythm O2. 2025; 5(12):883-889.

PMID: 39803626 PMC: 11721722. DOI: 10.1016/j.hroo.2024.09.017.


A microscale soft lithium-ion battery for tissue stimulation.

Zhang Y, Sun T, Yang X, Zhou L, Tan C, Lei M Nat Chem Eng. 2024; 1(11):691-701.

PMID: 39620147 PMC: 11606923. DOI: 10.1038/s44286-024-00136-z.


Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers.

Reed S, Yang J, Wallace M, Sutphin J, Reed Johnson F, Ozdemir S Circ Cardiovasc Qual Outcomes. 2024; 17(12):e011168.

PMID: 39569505 PMC: 11654446. DOI: 10.1161/CIRCOUTCOMES.124.011168.


Double Perclose increases the efficiency of leadless pacemaker implantation: A propensity score-matched analysis.

Rodriguez-Taveras J, Patino C, Matos C, Velasco A, Alviz I, Tadros T Heart Rhythm O2. 2024; 5(10):750-753.

PMID: 39524051 PMC: 11549639. DOI: 10.1016/j.hroo.2024.07.018.


BRASH syndrome: A rare but reversible cause of sinus node dysfunction.

Habib A, Butt K, Ibrahim R, Shaaban A, Lee H HeartRhythm Case Rep. 2024; 10(6):398-401.

PMID: 38983885 PMC: 11228057. DOI: 10.1016/j.hrcr.2024.03.005.


References
1.
Tjong F, Knops R, Neuzil P, Petru J, Sediva L, Wilde A . Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). Circulation. 2018; 137(6):633-635. DOI: 10.1161/CIRCULATIONAHA.117.030106. View

2.
Tarakji K, Wazni O, Harb S, Hsu A, Saliba W, Wilkoff B . Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014; 16(10):1490-5. DOI: 10.1093/europace/euu147. View

3.
Kirkfeldt R, Johansen J, Nohr E, Jorgensen O, Nielsen J . Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2013; 35(18):1186-94. PMC: 4012708. DOI: 10.1093/eurheartj/eht511. View

4.
Reddy V, Exner D, Cantillon D, Doshi R, Bunch T, Tomassoni G . Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med. 2015; 373(12):1125-35. DOI: 10.1056/NEJMoa1507192. View

5.
Tjong F, Brouwer T, Kooiman K, Smeding L, Koop B, Soltis B . Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator. J Am Coll Cardiol. 2016; 67(15):1865-1866. DOI: 10.1016/j.jacc.2016.02.039. View